BOSTON SCIENTIFIC CORP — Director's Dealing 2018

Feb 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-02-07

Reporting Person: Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-07	Common Stock	M	85227.0000	$12.5200	Acquired	237152.0000	Direct
2018-02-07	Common Stock	S	85227.0000	$26.4784	Disposed	151925.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-07	Stock Option (Right to Buy)	$12.5200	M	85227.0000	Disposed	2018-02-12	Common Stock (85227.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	77323.0000	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $26.39 to $26.57, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F4: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F5: Grant to the reporting person of an option to purchase 85,227 shares of common stock vesting in four annual increments beginning on February 12, 2009, the first anniversary of the grant.